December 6-7 | Buck Institute for Aging | Novato, CA
Explore the conference themes below! Gain key insights into how the commercialization of aging research happens. You will hear from those leading the charge at longevity biotech startups, government leaders, & top investors.
Expect focused 15-minute sessions mixed with 40-minute panel discussions from executives, scientists, and division heads who are successfully leading age-related disease programs. Hear topics including…
Longevity Drug DISCOVERY
Hear from leading R&D leaders on novel approaches to developing longevity therapeutics. Use cases covered here include:
- AI-Enabled Discovery
- Epigenetic/Bio Clocks
- Regenerative Medicine
- Biomarkers & Surrogate Biomarkers
- Gene Therapies
- And more.
ALTERNATIVE Financing MODELS
Learn the longevity financing landscape. Topics include:
- Venture-Backed Longevity
- Pharma Funding
- Decentralized Autonomous Organizations (DAOs)
- Crowdfunding
- And more.
New APPROACHES TO CLINICAL TRIALS
Using drugs to directly treat aging is a new phenomenon. Clinical trial strategies and the regulatory framework around longevity is a work in progress. Topics in this track include:
- Running Longevity Clinical Trials
- How Regulators View Aging Drugs
- Political Perspectives
- And more.
BUILDING LONGEVITY COMPANIES
Learn the strategies that entrepreneurs are using to build longevity biotech companies. Topics in this track include:
- Tackling age-related disease head on
- Dog and pet aging
- Beauty & cosmetics
- Fertility
- And more.
